◆英語タイトル:Bio Techne Corp (TECH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013171
◆発行会社(調査会社):
GlobalData
◆発行日:2017年11月27日
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Bio Techne Corp (Bio Techne), develops manufactures and sells biotechnology products and instruments for research and clinical diagnostics. The company provides proteins and antibodies, and related immunoassays and other reagents for research under brands such as R&D Systems, Novus, Biologicals and Tocris Bioscience.. It also develops and manufactures biotechnological products such as purified proteins, assays, enzymes, diagnostic kits and antibodies, among others. Bio Techne’s products find application in scientific investigations into biological processes and to find out the nature and progress of particular diseases. The company markets its products through its distribution centers across the world. It provides its products to research and clinical diagnostic communities. Bio Techne is headquartered in Minneapolis, Minnesota, the US.
Bio Techne Corp (TECH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Bio Techne Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Bio Techne Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Bio Techne Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Bio Techne Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Bio Techne Corp, Medical Devices Deals, 2011 to YTD 2017 10
Bio Techne Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Bio Techne Corp, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Cell Biosciences Secures US$13 Million In Second Tranche Of Series F Financing 13
Partnerships 14
COPD Foundation Enters into Agreement with Bio Techne 14
Indica Labs Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 15
MicroMatrices Associates Enters into Co-Development Agreement with Advanced Cell Diagnostics 16
Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 17
Ventana Medical Systems Enters Into Co-Promotion Agreement With Advanced Cell Diagnostics 18
Advanced Cell Diagnostics Enters Into Co-Development Agreement With Definiens 19
Licensing Agreements 20
Bio-Techne Enters into Licensing Agreement with MRC for Protein Synthesis Technology 20
Equity Offering 21
Astute Medical Raises USD43 Million in Private Palcement of Shares 21
ProteinSimple Withdraws IPO 22
ChemoCentryx Completes Private Placement Of Shares For US$5 Million 23
Acquisition 24
Bio Techne Acquires Trevigen 24
Bio-Techne Acquires Zephyrus Biosciences 25
Bio-Techne Acquires Cyvek 26
Bio-Techne Completes Acquisition of ProteinSimple for USD308 Million 27
Bio-Techne Acquires Novus Biologicals for USD60 Million 29
Bio-Techne Acquires Shanghai PrimeGene Bio-Tech 30
Novus Biologicals Acquires Imgenex, Biotech Company 31
Techne Acquires Tocris Holdings 32
Techne Acquires Boston Biochem And Boston Biochem 33
Bio Techne Corp – Key Competitors 34
Bio Techne Corp – Key Employees 35
Bio Techne Corp – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 38
Financial Announcements 38
Oct 31, 2017: Bio-Techne Releases First Quarter Fiscal 2018 Results 38
Aug 08, 2017: Bio-Techne Releases Fourth Quarter Fiscal 2017 Results 40
Feb 07, 2017: Bio-Techne Releases Second Quarter Fiscal 2017 Results 43
Oct 31, 2016: Bio-Techne Releases First Quarter Fiscal 2017 Results 45
Aug 17, 2016: Bio-Techne Releases Fourth Quarter Fiscal 2016 Results 47
May 03, 2016: Bio-Techne Releases Third Quarter Fiscal 2016 Results 50
Feb 02, 2016: Bio-Techne Releases Second Quarter Fiscal 2016 Results 52
Corporate Communications 54
Oct 26, 2017: Bio-Techne Adds Two New Directors to Its Board 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55
List of Tables
Bio Techne Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Bio Techne Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Bio Techne Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Bio Techne Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Bio Techne Corp, Deals By Therapy Area, 2011 to YTD 2017 9
Bio Techne Corp, Medical Devices Deals, 2011 to YTD 2017 10
Bio Techne Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Cell Biosciences Secures US$13 Million In Second Tranche Of Series F Financing 13
COPD Foundation Enters into Agreement with Bio Techne 14
Indica Labs Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 15
MicroMatrices Associates Enters into Co-Development Agreement with Advanced Cell Diagnostics 16
Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 17
Ventana Medical Systems Enters Into Co-Promotion Agreement With Advanced Cell Diagnostics 18
Advanced Cell Diagnostics Enters Into Co-Development Agreement With Definiens 19
Bio-Techne Enters into Licensing Agreement with MRC for Protein Synthesis Technology 20
Astute Medical Raises USD43 Million in Private Palcement of Shares 21
ProteinSimple Withdraws IPO 22
ChemoCentryx Completes Private Placement Of Shares For US$5 Million 23
Bio Techne Acquires Trevigen 24
Bio-Techne Acquires Zephyrus Biosciences 25
Bio-Techne Acquires Cyvek 26
Bio-Techne Completes Acquisition of ProteinSimple for USD308 Million 27
Bio-Techne Acquires Novus Biologicals for USD60 Million 29
Bio-Techne Acquires Shanghai PrimeGene Bio-Tech 30
Novus Biologicals Acquires Imgenex, Biotech Company 31
Techne Acquires Tocris Holdings 32
Techne Acquires Boston Biochem And Boston Biochem 33
Bio Techne Corp, Key Competitors 34
Bio Techne Corp, Key Employees 35
Bio Techne Corp, Subsidiaries 36